Bengaluru, Karnataka May 25, 2023 (Issuewire.com) - Immunogen Pharmaceuticals Inc Celebrates Grand Opening at Manyata Embassy Business Park in Bengaluru
Immunogen Pharmaceuticals Inc, a leading biopharmaceutical company specializing in innovative immunotherapies, is thrilled to announce the grand opening of its new facility at Manyata Embassy Business Park in Bengaluru, Karnataka. This momentous occasion marks a significant milestone for Immunogen Pharmaceuticals Inc as it expands its presence in the vibrant biotech landscape of India.
The state-of-the-art facility, located at Outer Ring Rd, E-1, Nagavara, Bengaluru, Karnataka 560045, represents Immunogen Pharmaceuticals Inc's commitment to advancing healthcare and bringing breakthrough therapies to patients across the globe. With its strategic location in the heart of Bengaluru's thriving business district, the company aims to foster collaborations with local biotech partners and tap into the region's exceptional talent pool.
Immunogen Pharmaceuticals Inc's new facility at Manyata Embassy Business Park features cutting-edge laboratories, research and development facilities, and administrative spaces designed to encourage innovation and collaboration among its scientists and professionals. Equipped with the latest technological advancements, the facility will serve as a hub for groundbreaking research, development, and manufacturing of immunotherapies that have the potential to revolutionize patient care.
"We are delighted to open our new facility at Manyata Embassy Business Park, solidifying our presence in Bengaluru, a city renowned for its thriving biotech ecosystem," said Dr. Rajesh Sharma, CEO of Immunogen Pharmaceuticals Inc. "This expansion not only reflects our commitment to advancing healthcare globally but also allows us to harness the immense talent and expertise available in this region. We look forward to collaborating with the local scientific community and contributing to the growth of the biotech industry in India."
Immunogen Pharmaceuticals Inc's expansion into Bengaluru marks a significant step in the company's journey to deliver innovative immunotherapies to patients worldwide. The opening of the new facility represents a clear demonstration of Immunogen Pharmaceuticals Inc's dedication to fostering scientific advancements and driving positive change in the healthcare landscape.
About Immunogen Pharmaceuticals Inc:
Immunogen Pharmaceuticals Inc is a leading biopharmaceutical company dedicated to discovering, developing, and delivering innovative immunotherapies for patients suffering from cancer, autoimmune diseases, and other serious illnesses. With a commitment to advancing healthcare, Immunogen Pharmaceuticals Inc leverages cutting-edge science and technology to develop breakthrough therapies that have the potential to transform patient outcomes.
Media Contact:
John Smith
Director of Communications
Immunogen Pharmaceuticals Inc
Phone: +1-XXX-XXX-XXXX
Email: media@lmmunogen.com
Media Contact
Immunogen Pharmaceuticals Inc media@lmmunogen.com MANYATA EMBASSY BUSINESS PARK, Outer Ring Rd, E-1, Nagavara, Bengaluru, Karnataka 560045 https://lmmunogen.com
